2,264
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Improvement in clinical disease activity index when treatment selection is informed by the tumor necrosis factor-ɑ inhibitor molecular signature response classifier: analysis from the study to accelerate information of molecular signatures in rheumatoid arthritis

, , , , & ORCID Icon
Pages 801-807 | Received 27 Feb 2022, Accepted 13 Apr 2022, Published online: 23 Apr 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.